论文部分内容阅读
作者评估了术前血清游离ＰＳＡ百分比预测病理分期的可能性。在７个试验中心共收入前列腺癌患者３７９例，前列腺增生患者（ＢＰＨ）３９４例，年龄５０～７５岁。全部病人触诊均象ＢＰＨ，血清ＰＳＡ４～１０ｎｇ／ｍｌ者进行活检组织学诊断。３７９例中２６８例（７１％）行?
The authors evaluated the preoperative serum free PSA percentage to predict the likelihood of pathological staging. A total of 379 prostate cancer patients and 394 BPH patients aged 50-75 years were included in the seven pilot centers. All patients palpation as BPH, serum PSA4 ~ 10ng / ml biopsy histological diagnosis. Of the 379 cases, 268 (71%) performed?